Could a lung drug stop pancreatitis Flare-Ups?
NCT ID NCT06253117
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests a drug called pirfenidone, currently used for lung disease, to see if it can safely reduce repeat attacks of pancreatitis. About 60 adults who have had two or more pancreatitis episodes will receive either the drug or a placebo. The goal is to lower the number and severity of future attacks and related hospital visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
-
University of Iowa Health Care
RECRUITINGIowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could ozempic stop pancreatitis from coming back?
- Feeding tube breakthrough: enzyme device could ease digestion for pancreatitis patients
- Pancreas removal plus islet transplant: a new hope for chronic pancreatitis pain?
- New trial tests which diabetes drug works best for pancreatitis patients
- Pancreatitis patients sip their way to less inflammation in new juice trial
- Can a simple sample predict cancer? new study tracks kids with pancreatitis